Title: Biologic use and outcomes among adults with severe asthma treated by US subspecialists.
Citation: Ann Allergy Asthma Immunol
2022;129:467–474.e3.
Country: USA | Indication: Asthma
This is a pharma-supported study
http://tago.ca/35728746
Title: Biologic use and outcomes among adults with severe asthma treated by US subspecialists.
Citation: Ann Allergy Asthma Immunol
2022;129:467–474.e3.
Country: USA | Indication: Asthma
This is a pharma-supported study
Title: Biologic use and outcomes among adults with severe asthma treated by US subspecialists.
Citation: Ann Allergy Asthma Immunol
2022;129:467–474.e3.
Country: USA | Indication: Asthma
This is a pharma-supported study